neuro · clinical-trial
Semax
Heptapeptídeo derivado ACTH(4-10).
Status:clinical-trial
Updated:May 13, 2026
Contributors:2
Half-life
0.5 h
Routes
IN, SC
Typical dose
250–1000 mcg
Mechanism of action
Aumenta BDNF e NGF, neuroprotetor.
Reported applications
- · cognitive
- · neuroprotection
Frequently asked
What is Semax?
Heptapeptídeo derivado ACTH(4-10).
What is the half-life of Semax?
Reference half-life: approximately 0.5 hours. Individual pharmacokinetics may vary.
Is PX7 prescribing Semax?
No. PX7 is an educational reference and a community knowledge layer. It does not prescribe, sell, or recommend substances.
Explore the cluster
PX7 publishes educational and community-curated references on regenerative and longevity science. Nothing on this page is medical advice, prescription, or a recommendation to obtain or use any substance. Always consult a qualified clinician.